Biora Therapeutics (FRA:4ZU) Change In Payables And Accrued Expense : €10.37 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biora Therapeutics Change In Payables And Accrued Expense?

Biora Therapeutics's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was €5.23 Mil. It means Biora Therapeutics's Accounts Payable & Accrued Expense increased by €5.23 Mil from Jun. 2024 to Sep. 2024 .

Biora Therapeutics's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €8.72 Mil. It means Biora Therapeutics's Accounts Payable & Accrued Expense increased by €8.72 Mil from Dec. 2022 to Dec. 2023 .

Biora Therapeutics Change In Payables And Accrued Expense Historical Data

The historical data trend for Biora Therapeutics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biora Therapeutics Change In Payables And Accrued Expense Chart

Biora Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

20.15

-48.52

-27.89

-5.18

8.72

Biora Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															2.48	-0.68	1.59	4.24	5.23

Biora Therapeutics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.37 Mil.

Biora Therapeutics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Biora Therapeutics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Biora Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biora Therapeutics Inc (FRA:4ZU) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4330 La Jolla Village Drive, Suite 300, San Diego, CA, USA, 92122

Website

https://www.bioratherapeutics.com

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Biora Therapeutics Headlines

No Headlines